Skip to main content
TipRanks
Go Ultimate75% OFF

ThermoGenesis Holdings (THMO) Stock Price & Analysis

329 Followers

THMO Stock Chart & Stats

$0.00$0.00(0.00%)
At close: 9:30 AM EDT
$0$0.1$0.2$0.3Jul 29Aug 12Aug 27Sep 9Sep 23Oct 7Oct 25
Day’s Range
$0.02 - $0.02
52-Week Range
N/A
Previous Close
$0.18
Volume
N/A
Average Volume (3M)
10.93K
Market Cap
$1,585
Enterprise Value
$7.20M
Total Cash (Recent Filing)
$1.18M
Total Debt (Recent Filing)
$6.93M
Price to Earnings (P/E)
0.0
Beta
138.72
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Business Model Strength

ThermoGenesis's focus on automated cell processing technologies positions it well in the growing regenerative medicine field, offering potential for long-term revenue growth as demand for efficient cell therapy solutions increases.

Revenue Generation

The company's diversified revenue streams, including equipment sales and technology licensing, provide a stable foundation for cash generation, supporting its operations and potential growth in the biotechnology sector.

Industry Growth Potential

The expanding regenerative medicine market offers significant growth opportunities for ThermoGenesis, as its technologies align with industry trends towards automation and efficiency in cell therapy manufacturing.

Bears Say

Financial Instability

Negative equity indicates a precarious financial position, raising concerns about the company's solvency and ability to sustain operations without restructuring or additional capital.

Revenue Decline

Declining revenues reflect challenges in maintaining market share or product demand, which could hinder long-term growth prospects and necessitate strategic adjustments to reverse the trend.

Liquidity Issues

Persistent negative cash flows highlight liquidity challenges, potentially limiting the company's ability to invest in growth initiatives or weather financial downturns without external financing.

ThermoGenesis Holdings News

THMO FAQ

What is ThermoGenesis Holdings’s market cap?
ThermoGenesis Holdings’s market cap is $1,585.
When is ThermoGenesis Holdings’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ThermoGenesis Holdings’s earnings last quarter?
ThermoGenesis Holdings released its earnings results on May 13, 2024. The company reported -$0.461 earnings per share for the quarter.
Is ThermoGenesis Holdings overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does ThermoGenesis Holdings pay dividends?
ThermoGenesis Holdings does not currently pay dividends.
What is ThermoGenesis Holdings’s EPS estimate?
ThermoGenesis Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ThermoGenesis Holdings have?
ThermoGenesis Holdings has 15,847,517 shares outstanding.
What happened to ThermoGenesis Holdings’s price movement after its last earnings report?
ThermoGenesis Holdings reported an EPS of -$0.461 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of ThermoGenesis Holdings?
Currently, no hedge funds are holding shares in THMO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology